Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial.
von Herrath M, Bain SC, Bode B, Clausen JO, Coppieters K, Gaysina L, Gumprecht J, Hansen TK, Mathieu C, Morales C, Mosenzon O, Segel S, Tsoukas G, Pieber TR; Anti-IL-21–liraglutide Study Group investigators and contributors. von Herrath M, et al. Lancet Diabetes Endocrinol. 2021 Apr;9(4):212-224. doi: 10.1016/S2213-8587(21)00019-X. Epub 2021 Mar 1. Lancet Diabetes Endocrinol. 2021. PMID: 33662334 Clinical Trial.
Effect of liraglutide on anthropometric measurements, sagittal abdominal diameter and adiponectin levels in people with type 2 diabetes treated with multiple daily insulin injections: evaluations from a randomized trial (MDI-liraglutide study 5).
Ahmadi SS, Filipsson K, Dimenäs H, Isaksson SS, Imberg H, Sjöberg S, Ahrén B, Dahlqvist S, Gustafsson T, Tuomilehto J, Hirsch IB, Lind M. Ahmadi SS, et al. Among authors: filipsson k. Obes Sci Pract. 2019 Mar 18;5(2):130-140. doi: 10.1002/osp4.324. eCollection 2019 Apr. Obes Sci Pract. 2019. PMID: 31019730 Free PMC article.
Glycogen metabolism in the glucose-sensing and supply-driven β-cell.
Andersson LE, Nicholas LM, Filipsson K, Sun J, Medina A, Al-Majdoub M, Fex M, Mulder H, Spégel P. Andersson LE, et al. Among authors: filipsson k. FEBS Lett. 2016 Dec;590(23):4242-4251. doi: 10.1002/1873-3468.12460. Epub 2016 Nov 5. FEBS Lett. 2016. PMID: 27943300 Free article.
Effect of Liraglutide on Times in Glycaemic Ranges as Assessed by CGM for Type 2 Diabetes Patients Treated With Multiple Daily Insulin Injections.
Sofizadeh S, Imberg H, Ólafsdóttir AF, Ekelund M, Dahlqvist S, Hirsch I, Filipsson K, Ahrén B, Sjöberg S, Tuomilehto J, Lind M. Sofizadeh S, et al. Among authors: filipsson k. Diabetes Ther. 2019 Dec;10(6):2115-2130. doi: 10.1007/s13300-019-00692-1. Epub 2019 Sep 28. Diabetes Ther. 2019. PMID: 31564026 Free PMC article.
Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3).
Dahlqvist S, Ahlén E, Filipsson K, Gustafsson T, Hirsch IB, Tuomilehto J, Imberg H, Ahrén B, Attvall S, Lind M. Dahlqvist S, et al. Among authors: filipsson k. BMJ Open Diabetes Res Care. 2018 Feb 24;6(1):e000464. doi: 10.1136/bmjdrc-2017-000464. eCollection 2018. BMJ Open Diabetes Res Care. 2018. PMID: 29527308 Free PMC article.
28 results